Technical Analysis for IFRX - InflaRx N.V.

Grade Last Price % Change Price Change
grade F 2.86 -1.38% -0.04
IFRX closed down 1.38 percent on Thursday, September 19, 2019, on 36 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Flat Down
See historical IFRX trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Down 3 Days in a Row Weakness 0.00%
20 DMA Support Bullish -1.38%
50 DMA Support Bullish -1.38%
Hammer Candlestick Bullish -1.38%
New Downtrend Bearish -1.72%
Upper Bollinger Band Walk Strength -5.30%
Upper Bollinger Band Walk Strength -5.30%
Overbought Stochastic Strength -5.30%

Older signals for IFRX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Inflarx NV, formerly Fireman BV, is a holding company for InflaRx GmbH, a Germany-based clinical-stage biopharmaceutical company. The Company's primary focus is on the development of monoclonal antibodies targeting activation products of the complement system for application in the treatment of life-threatening inflammatory diseases. Its lead product candidate, IFX-1, is an intravenously delivered first-in-class anti-C5a monoclonal antibody, undergoing Phase II clinical trial for the treatment of Hidradenitis Suppurativa (HS), a rare and chronic debilitating systemic inflammatory skin disease, and entering Phase II clinical trial for the treatment of ANCA-associated vasculitis (AAV) and other rare autoimmune diseases. The Company's product pipeline also includes IFX-2, which is in preclinical development.
Medicine Biotechnology Biopharmaceutical Medical Specialties Immunology Antibodies Immune System Monoclonal Antibodies Inflammatory Diseases
Is IFRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 53.1
52 Week Low 2.45
Average Volume 747,859
200-Day Moving Average 24.8181
50-Day Moving Average 2.8728
20-Day Moving Average 2.8795
10-Day Moving Average 2.979
Average True Range 0.1775
ADX 26.71
+DI 16.8861
-DI 23.2033
Chandelier Exit (Long, 3 ATRs ) 2.6575
Chandelier Exit (Short, 3 ATRs ) 3.1225
Upper Bollinger Band 3.1325
Lower Bollinger Band 2.6265
Percent B (%b) 0.46
BandWidth 17.572495
MACD Line -0.0806
MACD Signal Line -0.1375
MACD Histogram 0.0569
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.04
Resistance 3 (R3) 3.04 2.98 3.01
Resistance 2 (R2) 2.98 2.93 2.98 3.00
Resistance 1 (R1) 2.92 2.91 2.89 2.92 2.99
Pivot Point 2.86 2.86 2.85 2.86 2.86
Support 1 (S1) 2.80 2.81 2.77 2.80 2.73
Support 2 (S2) 2.74 2.79 2.74 2.72
Support 3 (S3) 2.68 2.74 2.71
Support 4 (S4) 2.68